Insider Transactions Reported by 32 Insiders of SAB Biotherapeutics, Inc.

Symbol
SABS, SABSW on Nasdaq
Location
Miami Beach, FL

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

SAB Biotherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Edward D. Hamilton 10%+ Owner $9,348,396 22 Oct 2021
Andrew Moin Director $3,847,299 29 Sep 2025
Sessa Capital (Master), L.P. Director $3,847,299 29 Sep 2025
Ilan Katz Director, 10%+ Owner $2,683,406 13 Oct 2021
Alexandra Kropotova Chief Medical Officer $144,808 03 Feb 2026
Michael G. King Jr. Chief Financial Officer $4,400 21 Feb 2024
Jay S. Skyler Director 16 Dec 2025
Mark William Conley Interim Chief Financial Officer, Vice President of Finance 04 Jun 2024
Frederick Finnegan Chief Business Officer 16 Mar 2022
David Charles Link Director 15 Jul 2024
Erick Lucera Director 16 Dec 2025
Jeffrey G. Spragens Director 15 Jul 2024
Christine Hamilton Power Director 15 Jul 2024
Thomas Charles Luke Chief Medical Officer 16 Mar 2022
Helen K. Ellias Director 16 Dec 2025
William James Polvino Director 16 Dec 2025
Charles Hiram Randall Chief Strategy Officer 22 Oct 2021
Carlos N. Carillo SVP Regulatory Affairs 22 Oct 2021
Mervyn Turner Director 22 Oct 2021
Jerry Lynn Pommer Chief Compliance Officer 16 Mar 2022
Hua Wu SVP Research & Product Dev. 22 Oct 2021
Russell P. Beyer Chief Financial Officer 14 Mar 2023
Bruce Kipp Erickson Chief Operating Officer 16 Mar 2022
David Charles Link Director 16 Dec 2025
David Zaccardelli Director 05 Jan 2026
Samuel J. Reich CEO, Director 05 Feb 2026
Rita Jain Director 05 Jan 2026
Christoph Lawrence Bausch Chief Operating Officer 03 Feb 2026
Eddie Joe Sullivan PRESIDENT, Director 03 Feb 2026
Lucy To Chief Financial Officer 03 Feb 2026
Melissa Vera Ullerich Chief Communications Officer 16 Mar 2022
Scott Giberson Director 16 Dec 2025

Recent Insider Transactions by Companies or Individuals for SAB Biotherapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Eddie Joe Sullivan SABS Stock option (right to buy) Award 3,000,000 3,000,000 03 Feb 2026 Direct
Christoph Lawrence Bausch SABS Stock option (right to buy) Award 1,800,000 1,800,000 03 Feb 2026 Direct
Lucy To SABS Stock option (right to buy) Award 2,400,000 2,400,000 03 Feb 2026 Direct
Alexandra Kropotova SABS Stock option (right to buy) Award 2,400,000 2,400,000 03 Feb 2026 Direct
Samuel J. Reich SABS Stock option (right to buy) Award 4,800,000 4,800,000 03 Feb 2026 Direct
Rita Jain SABS Stock Option (right to buy) Award 240,000 240,000 05 Jan 2026 Direct
David Zaccardelli SABS Stock Option (right to buy) Award 240,000 240,000 05 Jan 2026 Direct
Jay S. Skyler SABS Stock Option (right to buy) Award 150,000 150,000 16 Dec 2025 Direct
William James Polvino SABS Stock Option (right to buy) Award 150,000 150,000 16 Dec 2025 Direct
Erick Lucera SABS Stock option (right to buy) Award 150,000 150,000 16 Dec 2025 Direct
Helen K. Ellias SABS Stock Option (right to buy) Award 150,000 150,000 16 Dec 2025 Direct
Scott Giberson SABS Stock Option (right to buy) Award 150,000 150,000 16 Dec 2025 Direct
David Charles Link SABS Stock Option (right to buy) Award 150,000 150,000 16 Dec 2025 Direct
Alexandra Kropotova SABS Common Stock Tax liability -2.18% -988 44,284 11 Dec 2025 Direct
Andrew Moin SABS Common Stock Options Exercise 379.5% 1,740,000 2,198,457 29 Sep 2025 See Footnote.
Andrew Moin SABS Series B Convertible Preferred Stock Options Exercise -7.61% -17,400 211,100 29 Sep 2025 See Footnote.
Sessa Capital (Master), L.P. SABS Common Stock Options Exercise 379.5% 1,740,000 2,198,457 29 Sep 2025 Direct
Sessa Capital (Master), L.P. SABS Series B Convertible Preferred Stock Options Exercise -7.61% -17,400 211,100 29 Sep 2025 Direct
Alexandra Kropotova SABS Common Stock Tax liability -4.18% -1,977 45,272 19 Sep 2025 Direct
Samuel J. Reich SABS Stock Option (right to buy) Award 4,800,000 4,800,000 26 Aug 2025 Direct
Lucy To SABS Stock Option (right to buy) Award 1,200,000 1,200,000 26 Aug 2025 Direct
Alexandra Kropotova SABS Stock Option (right to buy) Award 2,400,000 2,400,000 26 Aug 2025 Direct
Christoph Lawrence Bausch SABS Stock Option (right to buy) Award 600,000 600,000 26 Aug 2025 Direct
Eddie Joe Sullivan SABS Stock Option (right to buy) Award 3,000,000 3,000,000 26 Aug 2025 Direct
Sessa Capital (Master), L.P. SABS Warrants (right to buy) Award 342,750 228,500 22 Jul 2025 Direct
Sessa Capital (Master), L.P. SABS Series B Convertible Preferred Stock Award 228,500 228,500 22 Jul 2025 Direct
Andrew Moin SABS Warrants (right to buy) Award 342,750 228,500 22 Jul 2025 See Footnote.
Andrew Moin SABS Series B Convertible Preferred Stock Award 228,500 228,500 22 Jul 2025 See Footnote.
Alexandra Kropotova SABS Common Stock Tax liability -2.43% -1,179 47,249 27 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.